Similar articles

• Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.

  Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G. Konstantinides SV, et al. J Am Coll Cardiol. 2017 Mar 28;69(12):1536-1544. doi: 10.1016/j.jacc.2016.12.039. J Am Coll Cardiol. 2017. PMID: 28335835 Clinical Trial.
• Predictors of long-term clinical outcome of patients with acute massive pulmonary embolism after thrombolytic therapy.

  Liu P, Meneveau N, Schiele F, Bassan JP. Liu P, et al. Chin Med J (Engl). 2003 Apr;116(4):503-9. Chin Med J (Engl). 2003. PMID: 12875711
• [Long-term outcome of acute massive pulmonary thromboembolism following thrombolysis].

  Liu P, Meneveau N, Schiele F, Bassand JP. Liu P, et al. Zhonghua Nei Ke Za Zhi. 2002 Nov;41(11):750-3. Zhonghua Nei Ke Za Zhi. 2002. PMID: 12485521 Chinese.
• A contemporary approach to thrombolytic therapy for pulmonary embolism.

  Goldhaber SZ. Goldhaber SZ. Vasc Med. 2000;5(2):115-23. doi: 10.1177/1358836X0000500208. Vasc Med. 2000. PMID: 10943588 Review.
• Thrombolysis in acute pulmonary thromboembolism.

  Vyas PA, Donato AA. Vyas PA, et al. South Med J. 2012 Oct;105(10):560-70. doi: 10.1097/SMJ.0b013e318268dbca. South Med J. 2012. PMID: 23038490 Review.